How much does PT-141 cost?

PT-141 prices at a glance

Bremelanotide is sold in two legitimate ways: the FDA-approved brand autoinjector Vyleesi, approved for acquired, generalized HSDD in premenopausal women, and compounded PT-141 prepared by a licensed pharmacy on a prescription. Compounded PT-141 is not FDA-approved, and any use outside that one approved indication is off-label. There is also a third tier you will see in search results, gray-market "research" vials, which is not a clinical option at all.

What actually drives the price

PT-141 is dosed as needed rather than daily, so the honest unit of cost is not really the month, it is how often you use it. A few things explain most of the spread between quotes:

• Brand vs compounded. Vyleesi carries a brand manufacturer's list price. Compounded PT-141, prepared by a licensed pharmacy, is generally far less expensive, and it is not FDA-approved.
• How often you use it. A vial lasts a different length of time for someone dosing a few times a month than for someone dosing weekly. Ask how many doses a supply is expected to cover, not just what the month costs.
• Dose and format. Injection is the studied and approved route. Compounded nasal sprays and troches are priced differently and are not supported by the same evidence. See PT-141 dosage and formats.
• What is bundled. Some prices are medication only. Others include the consult, provider check-ins, and shipping. Compare the all-in number.
• Insurance. Coverage for low desire is limited even for the approved brand, and compounded medications are effectively always paid out of pocket.

What you get at Expert Health

Expert Health prices compounded PT-141 at $166 per month, or $497 for about a 10-week supply. The price is built to be all-in rather than a teaser:

• A free call with a health specialist to talk through your goals, with no obligation to buy
• A US-licensed provider who reviews your history and decides whether PT-141 is appropriate
• PT-141 compounded by a licensed US pharmacy and prescribed for you
• Free, discreet shipping to your door
• Provider check-ins so your plan is matched to how you actually respond

You see your plan price before you pay, and a provider has to agree treatment is appropriate before anything ships. Compounded PT-141 is not FDA-approved, and use outside acquired, generalized HSDD in premenopausal women is off-label.

Does insurance cover PT-141 or Vyleesi?

Rarely. Treatments for low sexual desire sit in a category that many plans exclude outright, and coverage decisions for the approved brand vary widely by plan and often require prior authorization. Compounded PT-141 is generally not covered at all, because compounded medications are not FDA-approved products with a benefit code behind them.

• Brand Vyleesi. Some plans cover it for the approved indication with prior authorization, many do not. The manufacturer has offered savings programs at times. Check your formulary before assuming either way.
• Compounded PT-141. Treat it as an out-of-pocket cost. That is the norm across telehealth.
• HSA and FSA. Many people pay with HSA or FSA funds for a prescribed medication. Eligibility depends on your plan administrator, so confirm with them rather than with us.

Is the cheapest PT-141 a good idea?

Not on its own. Search for PT-141 and you will find vials sold as a "research chemical, not for human use" at a price no clinic can match. That gap is not efficiency. It is the prescription, the provider who checks your blood pressure history and your medication list, the pharmacy held to real standards, and the person you can call if something feels wrong, all removed from the transaction.

PT-141 has a known transient effect on blood pressure and is not appropriate for everyone, which is exactly why the cheap route is the wrong place to save. Read PT-141 side effects and safety, then where to get PT-141 online.

Frequently asked questions

Sources

1. Vyleesi (bremelanotide injection) Prescribing Information · U.S. FDA Label
2. Compounding and the FDA: Questions and Answers · U.S. Food and Drug Administration